Dietary flavanols reverse age-related memory decline — Findings strengthen link between specific brain region and normal memory decline – Dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults, revealed by researchers in Nature Neuroscience.
Yoga regulates stress hormones and improves quality of life for women with breast cancer undergoing radiation therapy – For women with breast cancer undergoing radiation therapy, yoga offers unique benefits beyond fighting fatigue. Researchers found that yoga exercises counteracted fatigue and improved ability to engage in their daily activities, better general health and better regulation of cortisol (stress hormone).
Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds – Avastin – bevacizumab failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting.
Study may impact guidelines for mitral valve surgery for severe ischemic mitral regurgitation — New findings showing mitral valve replacement may be more effective than mitral valve repair reported at AHA Scientific Sessions 2013 and in New England Journal of Medicine – The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation — mitral valve repair and mitral valve replacement.
Pazopanib shows better quality-of-life in advanced kidney cancer – Two oral targeted drugs — Pazopanib (Votrient) and sunitinib (Sutent) — approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, the safety profile and many measures of quality of life favored pazopanib.
Observation is safe, cost-saving in low-risk prostate cancer — Study suggests low-risk patients can forego immediate treatment – Many men with low-risk, localized prostate cancers can safely choose active surveillance or “watchful waiting” instead of undergoing immediate treatment and have better quality of life while reducing health care costs, according to a study by researchers at Dana-Farber Cancer Institute and Massachusetts General Hospital.